BioMimetic Q3 loss narrows

elawley@nashvillepost.com (Erin Lawley) — Fri, 06 Nov 2009 07:39:00 CST

Company starts enrolling for injectable product trials in Canada

BioMimetic soars on trial results

elawley@nashvillepost.com (Erin Lawley) — Wed, 14 Oct 2009 14:12:00 CST

Positive data from bone graft test gets Franklin company closer to crucial FDA approval

Mon, 22 Jun 2009 00:04:00 CST

Sam Lynch has BioMimetic on a steady growth path. Next up: Two important product launches [From our print edition featured in Monday's City Paper]

walker.duncan@nashvillepost.com (Walker Duncan) — Thu, 07 May 2009 15:38:00 CST

Despite red ink on balance sheet, company tops analyst expectations

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Mon, 06 Apr 2009 19:00:59 CST

Private placement will be followed by larger rights offering

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Mon, 23 Mar 2009 06:23:00 CST

Lynch adopts trading plan to unload almost 1 percent of biotech's stock

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Thu, 19 Jun 2008 08:07:00 CST

Healthways stashing cash, Habitat's capital campaign, the state of biotech in Tennessee, today's the day for a swim in the Cumberland, and more...

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Tue, 20 May 2008 15:06:00 CST

Danish company invests more than $5M over three weeks

geert.de.lombaerde@nashvillepost.com (Geert De Lombaerde) — Tue, 22 Apr 2008 06:53:59 CST

Also: Clarcor CFO sells big and Tennessee Commerce back in NASDAQ's good graces

walker.duncan@nashvillepost.com (Walker Duncan) — Fri, 28 Mar 2008 10:18:00 CST

After nosedive late yesterday, company responds to FDA and sees shares rocket forward